Last reviewed · How we verify
NCT06021236: MBI-CIED
Efficacy of a Mindfulness-Based Intervention in Patients With Cardiovascular Implantable Electronic Device
NA trial testing mindfulness-based intervention in Mindfulness Training in 34 participants. Terminated before completion.
30 December 2025
Quick facts
| Lead sponsor | Chien Chih-Yin |
|---|---|
| Phase | NA |
| Status | Terminated |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | supportive care |
| Enrollment | 34 |
| Start date | 1 January 2024 |
| Primary completion | 30 December 2025 |
| Estimated completion | 30 December 2025 |
| Sites | 1 location across Taiwan |
Drugs / interventions tested
- mindfulness-based intervention
- CIED procedure routine care
Conditions studied
- Mindfulness Training — all drugs for Mindfulness Training →
- Cardiac Resynchronization Therapy Devices — all drugs for Cardiac Resynchronization Therapy Devices →
- Resilience, Psychological — all drugs for Resilience, Psychological →
- Anxiety — all drugs for Anxiety →
Sponsor
Chien Chih-Yin
Who can join
Adults 18 to 100, any sex, with Mindfulness Training or Cardiac Resynchronization Therapy Devices. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
An implantable cardiac defibrillator (implantable cardioverter-defibrillator; ICD) can effectively improve heart rhythm problems and reduce sudden death, and is widely used in the treatment of high-risk patients with fatal arrhythmias or heart rhythm problems that cannot be controlled by drugs . In the whole case of arrhythmia, after receiving home-based cardiac fibrillator treatment, Patients often experience uncertainty, feel the changes in heart, feel the shock of being shocked by the electric shock, and worry about death, These psychological distress, which were characterized by anxiety and depression. for universal. About 25% of patients present with symptoms of anxiety at the time of hospitalization, and 50% suffer from depression which seriously affects quality of life. Therefore, the main purpose of this study to alleviate the occurrence of anxiety and depression, promote disease patients to regain life adaptation, develop accessible care strategies with midfulness-based intervention to help patients overcome psychological distress, reduce stress, anxiety and prevent depression.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06021236
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of mindfulness-based intervention
Trials testing the same drug.
- NCT06298136 — The Effects of an Online Mindfulness-based Intervention for Children with Attention-Deficit/Hyperactivity Disorder · NA · recruiting
- NCT05941143 — Effect of Mindfulness on EEG Brain Activity for Cognitive and Psychological Well-being in the Elderly · NA · completed
Other recruiting trials for Mindfulness Training
Currently open trials in the same condition.
- NCT06454526 — Effects of Mindfulness-Based Program on Individual and Organizational Output of Frontline Manager Nurses: · NA · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06021236 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Chien Chih-Yin
- Last refreshed: 14 April 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06021236.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing